Specialty Diagnostix Scandinavia ApS: Financial statements 2025
CVR: 45427536
Specialty Diagnostix Scandinavia ApS (CVR 45427536) has filed annual accounts for 2025. In 2025, the company reported a gross profit of DKK 1,628,798 and a net result of DKK 700,284. Equity amounted to DKK 4,768,208. The solvency ratio was 91.5%. The company had 1 employee in the financial year.
- Gross Profit
- 1,628,798 kr.
- Profit/Loss
- 700,284 kr.
- Equity
- 4,768,208 kr.
- Total Assets
- 5,211,266 kr.
- Employees
- 1
Find more companies like Specialty Diagnostix Scandinavia ApS
Build lead lists with filters on industry, geography, size and financials — and export straight to Excel.
Try the lead list generatorEvents in 2025
As of February 18, 2025, Leif Brix Gottschalk is registered as director of Specialty Diagnostix Scandinavia ApS.
As of February 18, 2025, Leif Brix Gottschalk is registered as an owner of Specialty Diagnostix Scandinavia ApS with an ownership share of 100%.
Specialty Diagnostix Scandinavia ApS was founded on February 18, 2025.
About Specialty Diagnostix Scandinavia ApS
Specialty Diagnostix Scandinavia ApS is a Danish company of the type Anpartsselskab based in Humlebæk, founded in 2025. The company is registered under the industry Andre liberale, videnskabelige og tekniske tjenesteydelser i.a.n.. The management consists of Leif Brix Gottschalk. The company is owned by Leif Brix Gottschalk. In 2025, the company reported a gross profit of DKK 1,628,798 and a net result of DKK 700,284. Equity amounted to DKK 4,768,208.
